UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile

Molecular pharmaceutics, 2018-03, Vol.15 (3), p.934-946

2018

Volltextzugriff (PDF)

Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy

Molecular pharmaceutics, 2018-06, Vol.15 (6), p.2297-2306

2018

Volltextzugriff (PDF)

Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1761-1775

2016

Volltextzugriff (PDF)

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Journal of Nuclear Medicine, 2015-06, Vol.56 (6), p.914-920

2015

Volltextzugriff (PDF)

Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Journal of Nuclear Medicine, 2017-09, Vol.58 (Suppl 2), p.17S-26S

2017

Volltextzugriff (PDF)

Atomic Nanogenerators in Targeted Alpha Therapies: Curie's Legacy in Modern Cancer Management

Pharmaceuticals (Basel, Switzerland), 2020-04, Vol.13 (4), p.76

2020

Volltextzugriff (PDF)

Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties

Molecular pharmaceutics, 2017-02, Vol.14 (2), p.523-532

2017

Volltextzugriff (PDF)

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC

European journal of nuclear medicine and molecular imaging, 2021-03, Vol.48 (3), p.893-903

2021

Volltextzugriff (PDF)

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response

Frontiers in oncology, 2021-03, Vol.10, p.627379

2021

Volltextzugriff (PDF)

Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals

Bioconjugate chemistry, 2017-09, Vol.28 (9), p.2372-2383

2017

Volltextzugriff (PDF)

Recent Contributions to Quantitative Linguistics

1, 2015

Volltextzugriff (PDF)

Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities

Molecular pharmaceutics, 2022-03, Vol.19 (3), p.963-973

2022

Volltextzugriff (PDF)

Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics

Bioconjugate chemistry, 2021-08, Vol.32 (8), p.1617-1628

2021

Volltextzugriff (PDF)

Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.972-983

2021

Volltextzugriff (PDF)

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

Theranostics, 2020, Vol.10 (4), p.1678-1693

2020

Volltextzugriff (PDF)

[68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging

Pharmaceuticals (Basel, Switzerland), 2020-03, Vol.13 (3), p.38

2020

Volltextzugriff (PDF)

Bibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing

Frontiers in oncology, 2024-07, Vol.14, p.1397790

2024

Volltextzugriff (PDF)

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

EJNMMI research, 2017-01, Vol.7 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

Towards a Fractal Analysis of the Sign Language

Journal of quantitative linguistics, 2021-01, Vol.28 (1), p.77-94

2021

Volltextzugriff (PDF)

In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.4995-5004

2018

Volltextzugriff (PDF)

Alpha-Emitting Radionuclides: Current Status and Future Perspectives

Pharmaceuticals (Basel, Switzerland), 2024-01, Vol.17 (1), p.76

2024

Volltextzugriff (PDF)

Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.513

2024

Volltextzugriff (PDF)

Conference Report QUALICO 2014, Olomouc 29th May-1st June 2014, Czech Republic

Journal of quantitative linguistics, 2016-01, Vol.23 (1), p.1-4

Benešová, Martina

2016

Volltextzugriff (PDF)

Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy

Journal of Nuclear Medicine, 2021-10, Vol.62 (10), p.1475-1481

2021

Volltextzugriff (PDF)

Development of PSMA-1007-Related Series of 18F‑Labeled Glu-Ureido-Type PSMA Inhibitors

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.10897-10907

2020

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(50)
Humans
(36)
Computational Linguistics
(25)
Philosophy Of Language
(24)
Male
(23)
Animals
(21)
Mice
(18)
Prostate Cancer
(18)
Female
(17)
Oncology
(16)
Nuclear Medicine
(12)
Pharmacology & Pharmacy
(12)
Tumors
(11)
Ligands
(10)
Medicine
(10)
Medicine, Research & Experimental
(10)
Radiology, Nuclear Medicine & Medical Imaging
(10)
Research & Experimental Medicine
(10)
Tissue Distribution
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile

Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy

Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Atomic Nanogenerators in Targeted Alpha Therapies: Curie's Legacy in Modern Cancer Management

Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response

Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals

Recent Contributions to Quantitative Linguistics

Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities

Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics

Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

[68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging

Bibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

Towards a Fractal Analysis of the Sign Language

In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs

Alpha-Emitting Radionuclides: Current Status and Future Perspectives

Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?

Conference Report QUALICO 2014, Olomouc 29th May-1st June 2014, Czech Republic

Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy

Development of PSMA-1007-Related Series of 18F‑Labeled Glu-Ureido-Type PSMA Inhibitors

Suchergebnisse filtern